Table 3 Analysis of the differences of this assessment to baseline studies: only presenting colo-rectal, prostate and breast cancer (more 6 cases)
Type of cancer (number of Deaf cases) | Stage | Number observed in the sample studied (nomber) | % of the reference population | p-values. fisher’s exact test | Baseline studies |
|---|---|---|---|---|---|
Colo-rectal (n = 6) | I/II | – | 47% (17584) | 0.03 | PETRI (Fr) [24] (37,413 patients) |
III/IV | 100% (6) | 47% (17622) | |||
NDa | – | 6% (2207) | |||
Prostate (n = 11) | T1–2/N0 | 18% (2) | 87% (1889) | 0.04 | « Cancer de la prostate en France en 2001 » [21] (2181 patients) |
T3+ or N+ or M+ | 64% (7) | 13% (292) | |||
NDa | 18% (2) | – | |||
Breast (n = 15) | T1 | 33% (5) | 66% (18404) | 0.02 | « Breast cancer incidence: Decreasing trend in large tumours in women aged 50–74 » [22] (28,092 patients) |
T2+ | 60% (9) | 34% (9688) | |||
NDa | 7% (1) | – | |||
N0 | 53% (8) | 63% (17696) | 0.58 | ||
N+ | 40% (6) | 33% (9205) | |||
NDa | 7% (1) | 4% (1191) | |||
M0 | 93% (14) | 90.5% (25434) | 1 | ||
M+ | 1 (6.7%) | 4.5% (1268) | |||
NDa | – | 5% (1390) |